What does this service help with?
We will first identify the specific issues to be addressed and the scope of collaboration, taking into account product categories and current data adaptation.
The possibility of falling under FDA regulation, based on product use, type of radiation and technical parameters, is first judged.
Applicability and scope depend on the product, your business role and the agreed engagement. The service does not constitute FDA approval or certification.
We will first identify the specific issues to be addressed and the scope of collaboration, taking into account product categories and current data adaptation.
The requirements for the manufacture or export of lasers, X-rays, microwaves and other products that may be relevant to the regulation of radiation emissionses need to be identified on a case-by-case basis in relation to the type of product, the activities of the enterprise, the target market and the applicable regulations.
Identify information gaps before agreeing on documentation and responsibilities.
Review product characteristics, responsible businesses and facilities, activities and existing records to select the appropriate process.
Confirm requirements and open questions about registration, listing, documentation, labels or contact information relevant to the service.
Discuss required documents, responsibilities, timing and fees. The agreed scope governs the work.
If documents are incomplete, share the product and current stage first. You can provide the remaining details later.
Share the product, your role, target market and current stage.
Prepare relevant facility, product, technical or label records based on the service.
Define the applicable requirements, scope, documentation responsibilities and fees.
Work within the confirmed scope and discuss applicable maintenance.
Registration, listing or submission of supporting information does not confer FDA approval, certification or marketing authorization. Refer to current FDA requirements and the facts of your project.
The agreed delivery plan is available and the scope is confirmed; The volume of products, technical information gaps, changing wheels and the speed of client feedback affect the lead time.
Preparation by type of launch, performance standards and reporting applicability; The technical parameters, test information and feedback decision arrangements are not applicable to the FDA certification cycle for all products.
This classification, reporting preparation or labelling supports the non-alignment of FDA product approval fees. Whether additional regulatory fees are checked against products and procedures; The costs of testing, process modification, customs clearance and third-party technology are separately charged, and the cost of services is not commingled as official fees.
Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.
Testing, translation, software and other third-party work are quoted separately where needed.
Share intended use, ingredients or technical characteristics, production location, business role and current stage. We can use this information to discuss likely FDA requirements and service scope.